Reglan (metoclopramide), a prescription medication used to treat gastro esophageal reflux (GER) and gastro esophageal reflux disease (GERD) in children and adults has been linked with Tardive Dyskinesia, a potentially permanent movement disorder. Tardive Dyskinesia is a neurological disorder that consists of potentially irreversible, involuntary movements of the tongue, mouth, face, lips, and sometimes the arms, legs, and trunk. Both the risk of developing the syndrome and the likelihood that it will become irreversible are believed to increase with the duration of Reglan use and the total cumulative dose. On February 26, 2009, the U.S. Food and Drug Administration (FDA) announced that manufacturers of metoclopramide must add a black box warning to their drug labels to warn about the risks associated with its long-term or high-dose use. Individuals sustaining serious injuries may be entitled to receive compensation for medical expenses, lost wages, loss of physical capacity, pain, suffering, and mental anguish.

If you, or a loved one, has been prescribed Reglan and has suffered from one or more of these serious side effects, contact us immediately.